FDA approves nerve stimulator for people facing opioid withdrawal symptoms
Home Health News Latest Health News FDA approves nerve stimulator for people facing opioid withdrawal symptoms
RELATED ARTICLESMORE FROM AUTHOR
FDA Warns, Male Enhancement Products May Be Dangerous
FDA has furnished a warning letter regarding the male enhancement products which are unapproved and available at gas stations. It may seem fun to try those inexpensive but unreliable...
FDA Committee Recommends First Marijuana-Derived Drug
First prescription cannabidiol medicine has been voted by Federal Advisors for recommendation to get approval for treating epilepsy. Even the US. FDA advisory committee has voted in unison for...
‘Biosimilar’ drug Ogviri approved by FDA for breast and stomach cancer
For the treatment of certain breast and stomach cancers, the U.S. Food and Drug Administration (FDA) recently approved Ogiviri (tastuzumab-dkst), which is the nation's first biosimilar drug. FDA said...
Monthly dose of Buprenorphine for treating opioid addiction, approved by FDA
U.S. Food and Drug Administration has approved a once in a month injection of Buprenorphine for the treatment of opioid addiction. Dr. Scott Gottlieb, FDA Commissioner said that there...
FDA approves Helimbra, new drug to prevent bleeding episodes in Hemophilia A patients
The U.S. Food and Drug Administration (FDA) has approved Helimbra (Emicizumab-kxwh) for preventing or reducing bleeding episodes in some patients of Hemophilia A. People with Hemophilia A generally lack a...
FDA approves Mepsevii for Sly syndrome – a rare enzyme disorder
For the treatment of a rare, genetic disease, known as mucopolysaccharidosis type VII or Sly syndrome, a drug, named Mepsevii has been recently approved by the U.S. Food and...
